Other CTLA-4 inhibitors like Tremelimumab and PD-1 inhibitors like Pembrolizumab and Atezolizumab have also been tested alone and in combination in advanced pancreatic cancer. The gene discussed is CTLA4; the disease is familial pancreatic carcinoma.